AntoXa

Life-saving biodefense solutions

  • About Us
    • Management Team
  • Products
  • Investors
  • News
  • Contact

Life-saving biodefense solutions

March 30, 2017 By antoxa

We’re developing safe, effective drugs to combat bioterrorism and infectious disease.

Emerging biological and chemical threats pose a significant risk to national security and public health.

Governments everywhere are increasingly vigilant and investing billions of dollars in preparation for potential bioterrorism attacks and pandemic diseases.

AntoXa Corporation is a Canadian biopharmaceutical company developing medical countermeasures to protect military and civilian personnel from biological and chemical agents that might be used in terrorist attacks, as well as outbreaks of naturally occurring infectious diseases.

Our growing portfolio responds to the demand for safe, effective therapeutics for national stockpiles against a range of threats from weaponized toxic agents such as the ricin and sarin to viruses such as Ebola.

Read more.

Filed Under: Overview Tagged With: slider

High-quality plant-based pharmaceuticals

March 29, 2017 By antoxa

Our versatile, scalable platform is ideal for novel indications and new markets. AntoXa holds an exclusive licence to use PlantForm Corporation’s vivoXPRESS® biopharmaceutical manufacturing platform to produce countermeasures for ricin, sarin, soman and Ebola Sudan, as well as other biodefense therapeutics.

Key advantages of the vivoXPRESS® platform include:

  • rapid drug development and production timelines
  • high levels of drug expression
  • mammalian-type glycosylation (less risk of unwanted immune reactions)
  • reduced risk profiles versatility (for new product development)
  • unlimited scale-up capability (to respond quickly to increased demand), and
  • manufacturing costs as much as 90 per cent lower than those for mammalian cell technology systems.

Read more.

Filed Under: Overview Tagged With: slider

Latest News

AntoXa Corporation awarded contract extension with federal government to develop plant-made protein for potential coronavirus therapy

August 17, 2021

DRDC-funded project aims to develop recombinant human ...
Read more >

AntoXa awarded federal government contract for anti-nerve agent enzyme

March 20, 2019

GUELPH, Ontario, Canada, March 20, 2019 — AntoXa Corporation has been ...
Read more >

Ashley J. Meyers appointed President and COO of AntoXa Corporation

Ashley J. Meyers appointed President and COO of AntoXa Corporation

December 20, 2018

Guelph, Ont., Canada, Dec. 20, 2018 — AntoXa Corporation announced today ...
Read more >

About Us

Plant-made biopharmaceuticals for a safer world. AntoXa Corporation is a Canadian biopharmaceutical company developing medical countermeasures to protect military and civilian personnel from biological and chemical agents that might be used in terrorist attacks, as well as outbreaks of naturally ...
Read more >

Global Demand for Biodefense Therapeutics

Governments are investing billions of dollars preparing for potential bioterrorism attacks and ...
Read more >

Subscribe to our Newsletter

vivoXPRESS® MANUFACTURING SYSTEM
The tobacco-plant-based vivoXPRESS® manufacturing platform offers several advantages over the mammalian and bacterial cell culture systems used to produce most recombinant protein pharmaceuticals. Here’s how it works.

BioPharming Info Centre

Biopharming, also known as plant molecular farming, refers to the use of genetically modified plants to produce a wide range of pharmaceuticals and industrial products. See our Biopharming Info Centre to Learn more about the science and history of using plants to produce complex therapeutic proteins.

Copyright © 2022 · AntoXa Corporation | Site by DigitalNomad.marketing and Curry Gunn & Associates